https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-07-01 / Int. J. Oncol. 2002 Jul;21(1):85-932002-07-01 00:00:002020-06-23 09:44:19Human tumor cell infection by Newcastle Disease Virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-30 / N. Engl. J. Med. 2002 May;346(22):1752-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-30 / N. Engl. J. Med. 2002 May;346(22):1752-32002-05-30 00:00:002019-02-15 08:35:36Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Hepatol. Res. 2002 May;23(1):38-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Hepatol. Res. 2002 May;23(1):38-472002-05-01 00:00:002019-02-15 08:37:57Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Int J Hyperthermia 2002 May-Jun;18(3):253-662002-05-01 00:00:002019-02-15 09:17:54A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / J. Clin. Oncol. 2002 May;20(9):2251-662002-05-01 00:00:002019-02-15 09:22:28Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-3052002-05-01 00:00:002019-02-15 08:51:10Optimizing dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Blood 2002 Apr;99(7):2512-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Blood 2002 Apr;99(7):2512-72002-04-01 00:00:002019-02-15 08:51:11Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Haematologica 2002 Apr;87(4):400-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Haematologica 2002 Apr;87(4):400-72002-04-01 00:00:002019-02-15 09:25:49Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-442002-04-01 00:00:002002-04-01 00:00:00Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Nihon Geka Gakkai Zasshi 2002 Apr;103(4):376-802002-04-01 00:00:002002-04-01 00:00:00[Immunotherapy for esophageal carcinoma]
